Archived App (Last seen on 11 Dec 2025)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
This app facilitates participation in a cognitive assessment sub-study related to emerging infectious diseases. It is designed for eligible adult service members and beneficiaries who are enrolled in the main study and meet specific testing or vaccination criteria for COVID-19.
What's New in EPICC Study
1.0
July 23, 2022
Developer apps
FAQ
What is EPICC Study?
EPICC Study is an application that allows eligible adult DoD service members and beneficiaries to participate in a cognitive assessment sub-study focused on emerging infectious diseases like COVID-19. Participation requires enrollment in the main study and meeting specific eligibility criteria.
Who can use EPICC Study?
The app is available to adult (18+) DoD active and non-active duty service members and beneficiaries who are eligible for MHS care. You must also meet criteria for COVID-19 testing or vaccination and be enrolled in the main EPICC Study.
Is EPICC Study free to use?
Yes, EPICC Study is available for free. There are no costs associated with downloading or using the application.
What devices does EPICC Study support?
EPICC Study is supported on iPhone and iPod devices. It is not currently available for Android or other platforms.
When was EPICC Study last updated?
EPICC Study was last updated on July 23, 2022, with version 1.0. This was also its release date.
What is the age rating for EPICC Study?
EPICC Study has an age rating of 17+. This indicates that the content is generally suitable for teenagers and adults.
Does EPICC Study have ads?
No, EPICC Study does not contain advertisements. The application is ad-free, allowing for an uninterrupted user experience.
What kind of medical information does EPICC Study collect?
EPICC Study focuses on the epidemiology, immunology, and clinical characteristics of emerging infectious diseases. It involves a cognitive assessment sub-study for participants meeting specific COVID-19 related criteria.
